Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185562 · ClinicalTrials.gov registry record · Phase 2
A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00185562: Completed Phase 2 study, sponsored by Stanford University.
NCT00185562 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185562, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
A 12 week trial of Adalimumab in subjects with active erosive inflammatory OA who have ahd an inadequate response to NSAID therapy
Interventions
- DRUG Adalimumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185562
The ClinicalTrials.gov registry entry for NCT00185562 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adalimumab is the first listed.
NCT00185562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185562 about?
NCT00185562 is a clinical study titled "A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis". A 12 week trial of Adalimumab in subjects with active erosive inflammatory OA who have ahd an inadequate response to NSAID therapy
What is the current status of trial NCT00185562?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2005-06. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00185562?
The interventions under investigation include: Adalimumab (DRUG).
Who is sponsoring clinical trial NCT00185562?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.